Significant impact made in reduction of cancer related deaths

Trump does his utmost to bow again

The report finds death rates saw their biggest drop yet from 2016 to 2017. Reportedly, from 1992 to 2017, total cancer deaths have declined by around 29%, assessed at up to 3 million prevented deaths. Apart from this, a fall in mortality for four significant cancers - colon, prostate, lung, and breast, plays a crucial role. Even more, the effort includes the contribution of enhanced lung cancer survival.

Since 1991, the incidence of lung cancer has declined twice as fast in men as it has in women (51% vs 26%, respectively), which the researchers noted "reflect [s] historical differences in tobacco uptake and cessation, as well as upturns in female smoking prevalence in some birth cohorts".

The decline in the mortality rate over the past 26 years has been steady. The annual report estimates the number of new cancer cases and deaths expected in the United States each year.

According to a study in the journal Lancet last year, an individual diagnosed with pancreatic cancer between 2010 and 2014 had almost twice the likelihood of surviving five years in the US than in the U.K. The five-year survival rate for brain cancer in the 36.5 percent compared to 27.2 percent in France and 26.3 percent in the U.K. For stomach cancer the five-year survival rate is 33.1 percent in the USA compared to 26.7 percent in France and 20.7 percent in the U.K. Most women now know, for example, that mutations in the BRCA1 and BRCA2 genes increase the risk for breast and ovarian cancers. Over the past few years, the reduced number of mortalities has driven progress in the massive battle against cancer overall. Thus, despite the progress in reducing lung cancer incidence and extending survival for patients diagnosed with it, continued diligence to reduce smoking and understand the causes of this disease in nonsmokers is needed.

Melanoma experienced the steepest decline in cancer mortality due to immunotherapy drugs ipilimumab (Yervoy, Bristol-Myers Squibb Company) and vemurafenib (Zelboraf, Roche), approved by the FDA in 2011, according to the report. Besides this, liver cancer, accountable for the death of an increasing number of people every year, has finally slowed down its lethal march.



Latest news

Pierre-Emerick Aubameyang: Mikel Arteta laments Arsenal striker's ban being upheld
The Gunners are already poor enough away from home, but if you take Aubameyang out of the equation, they genuinely might be among the worst away teams in Europe's top 5 leagues, let alone the Premier League .

Google buys Irish tech firm Pointy for $163m
This ensures that search results for local retailers are shown alongside those from e-commerce giants like Amazon. Cummins studied mobile robotics at the University of Oxford, and was once rejected from a job at Google.

Minnesota Twins sign Josh Donaldson to four-year deal
He earned $23 million on a one-year deal with the Braves , his lone season in the NL in a decade-long major league career. Cron, who hit 25 homers in 125 games in 2019 but was hampered by a thumb injury that required offseason surgery.

Tourists face trial, deportation over Machu Picchu damage
According to French news agency AFP, the group comprised of one French woman, two Brazilians, two Argentines and a Chilean. Authorities also discovered feces inside the ancient temple, which is around 60 miles from the Andean city of Cusco.

Gangubai Kathiawadi: Alia Bhatt looks fierce in SLB's next
Vijay after being spotted at the Bhansali office, when quizzed on the same, revealed, "There is a film called "Gangubai". Gangubai Kathiawadi will be Bhansali's first film after Padmaavat , which released in 2018 amid much controversy.

Other news